MedPath

Establishment of prediction method of malignancy and treatment resistance by fibrotic stroma quantification of pancreatic cancer using iodine map

Not Applicable
Conditions
Pancreatic cancer
Registration Number
JPRN-UMIN000036842
Lead Sponsor
kobe university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
162
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have not been requested to participate in this study from the published information. Patients who are, or will be, participating in a clinical study with drug treatment interventions. Patients who the research representative judged inappropriate.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
oninvasively predict malignancy and treatment resistance of pancreatic cancer by quantitatively measuring the degree of fibrotic interstitium in pancreatic cancer using an iodine map obtained from dynamic contrast-enhanced CT imaged by Dual-Energy CT .
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath